Cargando…
Albumin Fusion at the N-Terminus or C-Terminus of HM-3 Leads to Improved Pharmacokinetics and Bioactivities
HM-3, an integrin antagonist, exhibits anti-tumor biological responses and therefore has potential as a therapeutic polypeptide. However, the clinical applications of HM-3 are limited by its short half-life. In this study, we genetically fused human serum albumin (HSA) to the N or C-terminus of HM-3...
Autores principales: | Li, Ting, Zhang, Han-Zi, Ge, Guang-Fei, Yue, Zhao-Rong, Wang, Ru-Yue, Zhang, Qian, Gu, Yan, Song, Mei-Juan, Li, Wen-Bo, Ma, Min-Zhi, Wang, Mei-Zhu, Yang, Hui, Li, Yang, Li, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472738/ https://www.ncbi.nlm.nih.gov/pubmed/34572270 http://dx.doi.org/10.3390/biomedicines9091084 |
Ejemplares similares
-
Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein
por: Wang, Meng, et al.
Publicado: (2022) -
Charged N-terminus of Influenza Fusion Peptide Facilitates Membrane Fusion
por: Worch, Remigiusz, et al.
Publicado: (2018) -
The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
por: Wu, Bei, et al.
Publicado: (2017) -
Tripeptide Self-Assembly into Bioactive Hydrogels: Effects of Terminus Modification on Biocatalysis
por: Kurbasic, Marina, et al.
Publicado: (2020) -
Polyoxazolines with a Vicinally Double-Bioactivated Terminus for Biomacromolecular Affinity Assessment
por: Pinzner, Florian, et al.
Publicado: (2021)